Arimidex Beats Tamoxifen as Breast Cancer Treatment
576428
Women with breast cancer were offered new hope yesterday by research hailed as the biggest advance in 30 years. The findings mark a watershed in breast cancer care and are expected to challenge
458471
12/8/04- the drug tamoxifen has long been the 1st line of therapy for preventing the return of breast cancer, but researchers say another drug may be more effective and could soon become the 1st choice treatment for post-menopausal women who&#39;ve had the
601151
NEW YORK  - Aromatase inhibitors, a class of drugs used to ward off the recurrence of breast cancer after surgery, increase the risk of cardiovascular disorders slightly more than does treatment with tamoxifen, a new study shows.
434863
The ATAC (Arimidex, tamoxifen, alone or in combination) trial is the largest and longest-running early breast cancer treatment study.
47710
Radiation treatments routinely given  after surgery to remove small breast tumors may not be  necessary for women over 70 if they are taking the cancer drug  tamoxifen, according to researchers.
747218
Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC.
397182
SAN ANTONIO - Dec. 9, 2004 â-esults of an ogoing study show that a new class of drug called aromatase inhibitors can cut the rate of breast cancer recurrence by 76 percent in certain older women.
371604
Letrozole tablets (Femara-Novartis) have been approved by FDA for the extended adjuvant treatment of postmenopausal women with early breast cancer who have received adjuvant tamoxifen therapy for 5 years.
256613
(letrozole) is the first therapy approved by theU.S. Food and Drug Administration (FDA) for the extended adjuvant treatmentof postmenopausal women with early breast cancer who have received adjuvant(post-surgery) tamoxifen therapy for five years
310366
San Antonio - A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.
329902
A new drug may give older women with early stages of breast cancer a better chance of beating the disease and stopping it returning and spreading.
399636
A drug currently used against advanced breast cancer may provide better protection against recurrence or spreading than standard medication for post-menopausal women who have been treated for early forms of the disease, Swiss pharmaceutical giant Novartis AG and independent researchers said Wednesday.
446242
Raloxifene (Evista) continues to be associated with more than a 50% reduction in breast cancer incidence beyond the first 4 years of treatment, according to a new study in the December 1 issue of the Journal of the National Cancer Institute.
134401
A drug currently prescribed to combat advanced breast cancer can now be used to help prevent the disease from recurring in women who have been treated for early forms of the disease, the US Food and Drug Administration ruled Friday.
156528
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug _ but how much benefit it offers is unclear.
534244
TUESDAY, March 13 (HealthDay News) -- GlaxoSmithKline&#39;s Tykerb (lapatinib) has been approved by the U.S. Food and Drug Administration to treat advanced breast cancer when other cancer drugs haven&#39;t succeeded, the agency said Tuesday.
163988
SAN ANTONIO Dec 8, 2004 - A newer drug clearly outperforms tamoxifen at preventing breast cancer from returning and should become the first-choice treatment for most women who have had the disease, doctors are reporting.